In a recent paper of the journal Progress in Cardiovascular Diseases, the authors rationalize on the potential of nutraceuticals to enhance interferon signaling and possibly counteract RNA viruses, including the new coronavirus COVID-19.
Reference: Mark F. McCarty, James J. DiNicolantonio, Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus, Progress in Cardiovascular Diseases, 2020, https://doi.org/10.1016/j.pcad.2020.02.007
Nutraceuticals to counter coronavirus COVID-19 https://t.co/jUToCK4fsu #Nutraceuticals #Coronavirus #COVID19 @erlesen @ShraboniGhosal @MarcoAlbuja @PepperPell @KatarinaVasili3 @HealthyFellow @medicosergio @H3nRasouli— INPST (@_INPST) February 29, 2020
Other social media channels: https://t.co/WO0pc6I3Q9 pic.twitter.com/Kp8NRbLRMM
The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferences, grants and funding opportunities, jobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, biotechnology, medicine and pharmacognosy research, and natural product science.